Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenstrom Macroglobulinemia (WM)

被引：4

作者：

Ailawadhi, Sikander ^{[1
]}

Parrondo, Ricardo D. ^{[2
]}

Laplant, Betsy ^{[3
]}

Alegria, Victoria R. ^{[4
]}

Elliott, Jamie B. ^{[5
]}

Zimmerman, Ashley ^{[6
]}

Heslop, Keisha ^{[5
]}

Chapin, Dustin ^{[7
]}

Sher, Taimur ^{[2
]}

Roy, Vivek ^{[4
]}

Rasheed, Ahsan ^{[4
]}

Paulus, Aneel ^{[1
]}

Chanan-Khan, Asher ^{[8
]}

机构：

[1] Mayo Clin, Div Hematol & Oncol, Jacksonville, FL USA

[2] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL USA

[3] Mayo Clin, Dept Quantitat Hlth Sci, Div Clin Trials & Biostat, Rochester, MN USA

[4] Mayo Clin, Comprehens Canc Ctr, Jacksonville, FL USA

[5] Mayo Clin, Dept Hematol Oncol, Jacksonville, FL USA

[6] Mayo Clin, Hematol Oncol, Jacksonville, FL USA

[7] Mayo Clin, Jacksonville, FL USA

[8] Mayo Clin, Div Hematol Oncol, Jacksonville, FL USA

来源：

关键词：

D O I：

10.1182/blood-2022-165377

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：9331 / 9332

页数：2